Q4 2024 DaVita Inc Earnings Call Transcript
Key Points
- DaVita Inc (DVA) achieved full-year adjusted operating income and adjusted EPS growth of 21% and 26% respectively, finishing in the top half of their guidance range.
- The company expanded its international presence, closing three out of four acquisitions in Latin America, with Brazil expected to close mid-year 2025.
- DaVita Inc (DVA) successfully integrated oral drugs into the dialysis benefit, potentially expanding access for up to 20% of patients who previously lacked coverage.
- The company demonstrated resilience in overcoming supply chain disruptions caused by Hurricane Helene, resuming new home patient admissions by year-end 2024.
- DaVita Inc (DVA) continues to invest in differentiated capabilities and plans to return excess capital to shareholders through share repurchases, aiming for double-digit EPS growth.
- Treatment volume growth was below expectations for 2024, with a flat outlook for 2025, impacted by supply constraints and missed treatments due to severe weather.
- Mortality and mistreatment rates remained elevated in the fourth quarter, negatively affecting new patient starts.
- The company incurred a $6 million operating income impact in Q4 2024 due to supply chain disruptions, with an estimated $30 million negative impact expected in 2025.
- Integrated Kidney Care (IKC) reported an adjusted operating loss of $35 million for 2024, with flat expectations for 2025.
- A $19 million reserve was recorded against aged accounts receivable in Brazil, impacting adjusted international operating income.
Good evening. My name is Michelle, and I will be your conference facilitator today. At this time, I would like to welcome everyone to the DaVita fourth-quarter 2024 earnings call. (Operator Instructions)
Mr. Eliason, you may begin.
Thank you and welcome to our fourth quarter conference call. I'm Nic Eliason, Group Vice President of Investor Relations, and joining me today are Javier Rodriguez, our CEO; and Joel Ackerman, our CFO.
Please note that during this call we may make forward-looking statements within the meaning of the federal securities laws. All of these statements are subject to known and unknown risks and uncertainties that could cause the actual results to differ materially from those described in the forward-looking statements.
For further details concerning these risks and uncertainties, please refer to our fourth-quarter earnings press release and our SEC filings, including our most recent annual report on Form 10-K, all subsequent quarterly reports on Form 10-Q, and other
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
